The absorbance at 570 nm was measured using a microplate reader (Epoch, BioTek, US)
FOXO4-DRI acts as a competitive inhibitor of this interaction binding directly to the transactivation domain 2 (TAD2) of p53, displacing FOXO4, and allowing phosphorylated p53 to be exported from the nucleus and directed to mitochondria, where it activates BAX, triggers caspase-3 cleavage (via the p53/BCL-2/Caspase-3 signalling pathway), and drives cell-intrinsic apoptosis
This cutting-edge manufacturing process not only ensures enhanced purity but also guarantees heightened potency, making them specifically tailored for injection use
iii) A ROS-responsive hydrogel matrix (G) has been synthesized, exhibiting superior ROS-scavenging capabilities, functioning as an intelligent drug reservoir that enables the controlled release of D-CuP at the wound interface while simultaneously attenuating inflammatory responses in the microenvironment 51